Bioventus Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
Forward P/E20.0021.8217.1721.50
P/S Ratio1.200.650.322.00
P/B Ratio3.701.500.391.61
Price/FCF18.1641.5790.94
Price/OCF17.6921.6337.46
PEG Ratio2.07
Enterprise Value Ratios
EV/Revenue1.901.511.182.45
EV/EBITDA18.4226.8825.38
EV/EBIT27.27382.6950.07
EV/FCF28.7597.14111.28
Profitability & Returns
Return on Equity (ROE)-0.22%-0.38%-0.31%0.03%0.10%
Return on Assets (ROA)0.03%0.00%-0.02%0.02%0.03%
Return on Invested Capital (ROIC)0.07%0.00%-0.04%0.04%0.07%
Return on Capital Employed (ROCE)0.08%0.00%-0.03%0.02%0.06%
Leverage & Solvency Ratios
Debt/Equity1.921.901.060.701.42
Debt/EBITDA5.5011.81719.648.233.83
Debt/FCF9.4252.7039.723.70
Liquidity Ratios
Current Ratio1.311.530.901.461.73
Quick Ratio0.800.910.550.931.43
Efficiency Ratios
Asset Turnover0.740.470.390.500.66
Inventory Turnover2.012.092.472.823.10
Yield & Distribution Ratios
Earnings Yield-0.05%-0.47%-0.98%0.02%
FCF Yield0.06%0.02%-0.15%0.01%
Payout Ratio1.21%
Buyback Yield-0.03%-0.02%-0.35%-8.28%